Publications by authors named "Chengkun Ye"

Claim this Profile
L
Lycorine hydrochloride interferes with energy metabolism to inhibit chemoresistant glioblastoma multiforme cell growth through suppressing PDK3.
Qingsheng Dong, Wanxiang Niu, Maolin Mu, Chengkun Ye, Pengfei Wu

Mol Cell Biochem· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The value of texture analysis in peritumoral edema of differentiating diagnosis between glioblastoma and primary brain lymphoma.
Zhuang Sha, Yunnong Song, Yihao Wu, Pei Sha, Chengkun Ye

Br J Neurosurg· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent progress of hydrogel-based local drug delivery systems for postoperative radiotherapy.
Yandong Xie, Mingxi Liu, Chang Cai, Chengkun Ye, Tangjun Guo

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chrysophanol Induced Glioma Cells Apoptosis via Activation of Mitochondrial Apoptosis Pathway.
Jia Gu, Sunil Rauniyar, Yan Wang, Wenjian Zhan, Chengkun Ye

Bioengineered· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.
Chengkun Ye, Bomin Pan, Haoyue Xu, Zongren Zhao, Jiawei Shen

J Mol Med (Berl)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy.
Zhenkun Zong, Lei Hua, Zhen Wang, Haoyue Xu, Chengkun Ye

Drug Deliv· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiopep-2 Modified Cationic Lipid-Poly-Lactic-Co-Glycolic Acid Delivery Temozolomide and DNA Repair Inhibitor Dbait to Achieve Synergetic Chemo-Radiotherapy Against Glioma.
Shun Li, Qian Xu, Liang Zhao, Chengkun Ye, Lei Hua

J Nanosci Nanotechnol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.
Chengkun Ye, Bomin Pan, Haoyue Xu, Zongren Zhao, Jiawei Shen

J Mol Med (Berl)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth.
Lei Hua, Guanghui Wang, Zhen Wang, Jiale Fu, Zhen Fang, Chengkun Ye

J Neurooncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivery of Doxorubicin from Hyaluronic Acid-Modified Glutathione-Responsive Ferrocene Micelles for Combination Cancer Therapy.
Hong-Lin Mao, Feng Qian, Shun Li, Jia-Wei Shen, Cheng-Kun Ye

Mol Pharm· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glioma growth by a GOLPH3 siRNA-loaded cationic liposomes.
Zixuan Yuan, Liang Zhao, Yafei Zhang, Shun Li, Bomin Pan, Chengkun Ye

J Neurooncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis